U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879834) titled 'Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening' on March 11.
Brief Summary: To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.
Study Start Date: Nov. 02, 2024
Study Type: OBSERVATIONAL
Condition:
Diabetic Retinopathy
Intervention:
DEVICE: taking fundus photos using non-mydriatic fundus camera
using artificial intelligence to identify diabetic retinopathy in the early stages using fundus photography.
Recruitment Status: RECRUITING
Sponsor: The Filatov Institute of Eye Diseases and T...